Structure

Physi-Chem Properties

Molecular Weight:  480.18
Volume:  485.279
LogP:  4.095
LogD:  3.699
LogS:  -3.846
# Rotatable Bonds:  9
TPSA:  114.68
# H-Bond Aceptor:  8
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.411
Synthetic Accessibility Score:  3.537
Fsp3:  0.296
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.031
MDCK Permeability:  1.4514300346490927e-05
Pgp-inhibitor:  0.033
Pgp-substrate:  0.019
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.075

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.038
Plasma Protein Binding (PPB):  98.88514709472656%
Volume Distribution (VD):  0.638
Pgp-substrate:  2.7335455417633057%

ADMET: Metabolism

CYP1A2-inhibitor:  0.65
CYP1A2-substrate:  0.921
CYP2C19-inhibitor:  0.916
CYP2C19-substrate:  0.076
CYP2C9-inhibitor:  0.898
CYP2C9-substrate:  0.946
CYP2D6-inhibitor:  0.873
CYP2D6-substrate:  0.894
CYP3A4-inhibitor:  0.821
CYP3A4-substrate:  0.471

ADMET: Excretion

Clearance (CL):  13.296
Half-life (T1/2):  0.918

ADMET: Toxicity

hERG Blockers:  0.247
Human Hepatotoxicity (H-HT):  0.062
Drug-inuced Liver Injury (DILI):  0.401
AMES Toxicity:  0.121
Rat Oral Acute Toxicity:  0.05
Maximum Recommended Daily Dose:  0.181
Skin Sensitization:  0.934
Carcinogencity:  0.564
Eye Corrosion:  0.003
Eye Irritation:  0.933
Respiratory Toxicity:  0.085

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC267091

Natural Product ID:  NPC267091
Common Name*:   Agastinol
IUPAC Name:   [(2R,3S,4S)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl 4-hydroxybenzoate
Synonyms:   agastinol
Standard InCHIKey:  GFXHOKACHHWSQG-KCPMXOJXSA-N
Standard InCHI:  InChI=1S/C27H28O8/c1-32-24-12-16(3-9-22(24)29)11-19-14-34-26(18-6-10-23(30)25(13-18)33-2)21(19)15-35-27(31)17-4-7-20(28)8-5-17/h3-10,12-13,19,21,26,28-30H,11,14-15H2,1-2H3/t19-,21-,26+/m1/s1
SMILES:  COc1cc(ccc1O)[C@@H]1OC[C@H]([C@H]1COC(=O)c1ccc(cc1)O)Cc1ccc(c(c1)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL517327
PubChem CID:   637406
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0003686] Furanoid lignans
        • [CHEMONTID:0001604] Tetrahydrofuran lignans
          • [CHEMONTID:0003422] 7,9'-epoxylignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[11908994]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. root n.a. PMID[1823989]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[31747281]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[8594148]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT466 Cell Line U-937 Homo sapiens IC50 = 15.2 ug.mL-1 PMID[573928]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC267091 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9931 High Similarity NPC243891
0.9474 High Similarity NPC469889
0.9351 High Similarity NPC45943
0.9329 High Similarity NPC476434
0.9306 High Similarity NPC67467
0.9221 High Similarity NPC216916
0.9205 High Similarity NPC469888
0.9189 High Similarity NPC472969
0.9128 High Similarity NPC98809
0.9128 High Similarity NPC476394
0.9103 High Similarity NPC223006
0.9103 High Similarity NPC134047
0.9103 High Similarity NPC173729
0.9103 High Similarity NPC272750
0.9057 High Similarity NPC180768
0.9038 High Similarity NPC144557
0.9032 High Similarity NPC53889
0.9026 High Similarity NPC226759
0.902 High Similarity NPC203757
0.8973 High Similarity NPC100675
0.8968 High Similarity NPC87317
0.8954 High Similarity NPC25127
0.8954 High Similarity NPC287504
0.8947 High Similarity NPC75695
0.8944 High Similarity NPC316539
0.8933 High Similarity NPC102934
0.8933 High Similarity NPC252402
0.8931 High Similarity NPC311912
0.8926 High Similarity NPC30890
0.8919 High Similarity NPC469615
0.8919 High Similarity NPC473090
0.8917 High Similarity NPC42797
0.8917 High Similarity NPC473445
0.891 High Similarity NPC476373
0.8903 High Similarity NPC289322
0.8903 High Similarity NPC133984
0.8903 High Similarity NPC143328
0.8903 High Similarity NPC114179
0.8903 High Similarity NPC160512
0.8903 High Similarity NPC156818
0.8903 High Similarity NPC68324
0.8903 High Similarity NPC38779
0.8897 High Similarity NPC281780
0.8896 High Similarity NPC300757
0.8896 High Similarity NPC180901
0.8896 High Similarity NPC145425
0.8889 High Similarity NPC44730
0.8889 High Similarity NPC131121
0.8889 High Similarity NPC295646
0.8875 High Similarity NPC88557
0.8868 High Similarity NPC43065
0.8861 High Similarity NPC89131
0.8861 High Similarity NPC291977
0.8861 High Similarity NPC100420
0.8859 High Similarity NPC469683
0.8859 High Similarity NPC223185
0.8844 High Similarity NPC326065
0.8839 High Similarity NPC104983
0.8839 High Similarity NPC471405
0.8839 High Similarity NPC291948
0.8839 High Similarity NPC88803
0.8839 High Similarity NPC300845
0.8839 High Similarity NPC250436
0.8831 High Similarity NPC327032
0.8831 High Similarity NPC191046
0.8831 High Similarity NPC194095
0.8828 High Similarity NPC90431
0.8828 High Similarity NPC471988
0.8824 High Similarity NPC151425
0.8819 High Similarity NPC67247
0.8816 High Similarity NPC473091
0.8816 High Similarity NPC261322
0.88 High Similarity NPC9370
0.88 High Similarity NPC287495
0.8797 High Similarity NPC476372
0.8797 High Similarity NPC476371
0.8792 High Similarity NPC46161
0.8792 High Similarity NPC160378
0.8792 High Similarity NPC239608
0.879 High Similarity NPC24627
0.879 High Similarity NPC24164
0.879 High Similarity NPC472962
0.879 High Similarity NPC472961
0.8784 High Similarity NPC253722
0.8784 High Similarity NPC31751
0.8784 High Similarity NPC253481
0.8782 High Similarity NPC35598
0.8782 High Similarity NPC222689
0.8782 High Similarity NPC472860
0.8776 High Similarity NPC288452
0.8776 High Similarity NPC289690
0.8774 High Similarity NPC10205
0.8766 High Similarity NPC157898
0.8766 High Similarity NPC474656
0.8765 High Similarity NPC247964
0.8758 High Similarity NPC216403
0.8758 High Similarity NPC21956
0.8758 High Similarity NPC41494
0.8758 High Similarity NPC202428
0.8758 High Similarity NPC300329
0.8758 High Similarity NPC186100
0.8758 High Similarity NPC266545
0.8758 High Similarity NPC62354
0.8742 High Similarity NPC100425
0.8725 High Similarity NPC477697
0.8725 High Similarity NPC470811
0.8725 High Similarity NPC106920
0.8725 High Similarity NPC477696
0.8725 High Similarity NPC273657
0.8718 High Similarity NPC470896
0.8718 High Similarity NPC473275
0.8718 High Similarity NPC227062
0.8718 High Similarity NPC318432
0.871 High Similarity NPC62051
0.8701 High Similarity NPC163883
0.8701 High Similarity NPC124842
0.8701 High Similarity NPC134905
0.8701 High Similarity NPC270268
0.8701 High Similarity NPC93498
0.8701 High Similarity NPC36130
0.8701 High Similarity NPC478268
0.8699 High Similarity NPC120852
0.8696 High Similarity NPC177362
0.8693 High Similarity NPC221091
0.8693 High Similarity NPC259576
0.869 High Similarity NPC176814
0.869 High Similarity NPC135127
0.869 High Similarity NPC68779
0.869 High Similarity NPC300776
0.869 High Similarity NPC4982
0.869 High Similarity NPC5310
0.8688 High Similarity NPC475738
0.8688 High Similarity NPC142614
0.8688 High Similarity NPC471788
0.8684 High Similarity NPC236166
0.8684 High Similarity NPC1580
0.8679 High Similarity NPC33298
0.8679 High Similarity NPC76687
0.8679 High Similarity NPC246024
0.8679 High Similarity NPC285108
0.8675 High Similarity NPC98356
0.8671 High Similarity NPC203020
0.8671 High Similarity NPC300680
0.8671 High Similarity NPC239818
0.8671 High Similarity NPC218471
0.8671 High Similarity NPC239966
0.8667 High Similarity NPC46880
0.8662 High Similarity NPC167098
0.8662 High Similarity NPC296044
0.865 High Similarity NPC469506
0.8649 High Similarity NPC147379
0.8645 High Similarity NPC19380
0.8645 High Similarity NPC61604
0.8645 High Similarity NPC137813
0.8645 High Similarity NPC178574
0.8645 High Similarity NPC146277
0.8645 High Similarity NPC245615
0.8645 High Similarity NPC65591
0.8645 High Similarity NPC299706
0.8645 High Similarity NPC308555
0.8645 High Similarity NPC115466
0.8645 High Similarity NPC115203
0.8634 High Similarity NPC83049
0.8634 High Similarity NPC118162
0.8634 High Similarity NPC200726
0.8634 High Similarity NPC320471
0.863 High Similarity NPC113295
0.8627 High Similarity NPC474903
0.8627 High Similarity NPC125570
0.8627 High Similarity NPC111785
0.8621 High Similarity NPC159418
0.8621 High Similarity NPC283823
0.8618 High Similarity NPC283081
0.8618 High Similarity NPC299090
0.8618 High Similarity NPC24257
0.8618 High Similarity NPC153620
0.8618 High Similarity NPC229264
0.8618 High Similarity NPC221383
0.8618 High Similarity NPC143892
0.8616 High Similarity NPC92589
0.8609 High Similarity NPC163898
0.8608 High Similarity NPC179914
0.8608 High Similarity NPC160780
0.8608 High Similarity NPC76211
0.8608 High Similarity NPC289811
0.86 High Similarity NPC229218
0.86 High Similarity NPC141817
0.86 High Similarity NPC169214
0.86 High Similarity NPC192597
0.86 High Similarity NPC176030
0.8599 High Similarity NPC150227
0.8599 High Similarity NPC165483
0.8591 High Similarity NPC29599
0.8591 High Similarity NPC9218
0.8591 High Similarity NPC28398
0.859 High Similarity NPC144801
0.859 High Similarity NPC43872
0.859 High Similarity NPC116850
0.859 High Similarity NPC291510
0.859 High Similarity NPC197188

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC267091 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8839 High Similarity NPD4868 Clinical (unspecified phase)
0.8733 High Similarity NPD6143 Clinical (unspecified phase)
0.8562 High Similarity NPD6980 Clinical (unspecified phase)
0.8411 Intermediate Similarity NPD4628 Phase 3
0.8408 Intermediate Similarity NPD1934 Approved
0.8393 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD6234 Discontinued
0.8373 Intermediate Similarity NPD7685 Pre-registration
0.8355 Intermediate Similarity NPD6190 Approved
0.8354 Intermediate Similarity NPD3818 Discontinued
0.8344 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6166 Phase 2
0.8333 Intermediate Similarity NPD6232 Discontinued
0.8303 Intermediate Similarity NPD5844 Phase 1
0.8293 Intermediate Similarity NPD7473 Discontinued
0.825 Intermediate Similarity NPD3882 Suspended
0.8239 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD3817 Phase 2
0.8176 Intermediate Similarity NPD37 Approved
0.816 Intermediate Similarity NPD7199 Phase 2
0.8137 Intermediate Similarity NPD4966 Approved
0.8137 Intermediate Similarity NPD4965 Approved
0.8137 Intermediate Similarity NPD4967 Phase 2
0.8125 Intermediate Similarity NPD1465 Phase 2
0.8125 Intermediate Similarity NPD2801 Approved
0.8121 Intermediate Similarity NPD230 Phase 1
0.8105 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD3764 Approved
0.8036 Intermediate Similarity NPD7074 Phase 3
0.8035 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD7228 Approved
0.7988 Intermediate Similarity NPD5494 Approved
0.7976 Intermediate Similarity NPD7054 Approved
0.7975 Intermediate Similarity NPD7075 Discontinued
0.7959 Intermediate Similarity NPD9494 Approved
0.7937 Intermediate Similarity NPD4380 Phase 2
0.7929 Intermediate Similarity NPD7472 Approved
0.7898 Intermediate Similarity NPD1511 Approved
0.7895 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7266 Discontinued
0.7852 Intermediate Similarity NPD3027 Phase 3
0.7848 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD8127 Discontinued
0.7808 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD1512 Approved
0.7792 Intermediate Similarity NPD2935 Discontinued
0.7791 Intermediate Similarity NPD7819 Suspended
0.7791 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD6386 Approved
0.7778 Intermediate Similarity NPD7411 Suspended
0.7778 Intermediate Similarity NPD6385 Approved
0.7778 Intermediate Similarity NPD6797 Phase 2
0.7758 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD6233 Phase 2
0.7744 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD1608 Approved
0.7733 Intermediate Similarity NPD7251 Discontinued
0.7733 Intermediate Similarity NPD6559 Discontinued
0.773 Intermediate Similarity NPD6801 Discontinued
0.7707 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD4110 Phase 3
0.7707 Intermediate Similarity NPD8166 Discontinued
0.7692 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6273 Approved
0.7688 Intermediate Similarity NPD7808 Phase 3
0.7682 Intermediate Similarity NPD6798 Discontinued
0.7673 Intermediate Similarity NPD6799 Approved
0.7654 Intermediate Similarity NPD7458 Discontinued
0.7647 Intermediate Similarity NPD6355 Discontinued
0.7639 Intermediate Similarity NPD9545 Approved
0.7633 Intermediate Similarity NPD5242 Approved
0.763 Intermediate Similarity NPD7038 Approved
0.763 Intermediate Similarity NPD7039 Approved
0.7625 Intermediate Similarity NPD2533 Approved
0.7625 Intermediate Similarity NPD2532 Approved
0.7625 Intermediate Similarity NPD2534 Approved
0.7614 Intermediate Similarity NPD8434 Phase 2
0.7613 Intermediate Similarity NPD1510 Phase 2
0.7607 Intermediate Similarity NPD6599 Discontinued
0.7595 Intermediate Similarity NPD3750 Approved
0.759 Intermediate Similarity NPD7768 Phase 2
0.7588 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD1549 Phase 2
0.7546 Intermediate Similarity NPD3455 Phase 2
0.7546 Intermediate Similarity NPD3226 Approved
0.7546 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD3749 Approved
0.7543 Intermediate Similarity NPD8313 Approved
0.7543 Intermediate Similarity NPD8312 Approved
0.7534 Intermediate Similarity NPD17 Approved
0.7532 Intermediate Similarity NPD447 Suspended
0.753 Intermediate Similarity NPD5353 Approved
0.753 Intermediate Similarity NPD5402 Approved
0.7529 Intermediate Similarity NPD7240 Approved
0.7529 Intermediate Similarity NPD3926 Phase 2
0.7516 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6959 Discontinued
0.75 Intermediate Similarity NPD919 Approved
0.7485 Intermediate Similarity NPD1653 Approved
0.7484 Intermediate Similarity NPD7003 Approved
0.747 Intermediate Similarity NPD8455 Phase 2
0.7468 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1240 Approved
0.7468 Intermediate Similarity NPD1613 Approved
0.7452 Intermediate Similarity NPD2796 Approved
0.7452 Intermediate Similarity NPD2438 Suspended
0.7451 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD5403 Approved
0.7407 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD2344 Approved
0.7401 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD2799 Discontinued
0.7389 Intermediate Similarity NPD7033 Discontinued
0.7386 Intermediate Similarity NPD7095 Approved
0.7383 Intermediate Similarity NPD9269 Phase 2
0.7372 Intermediate Similarity NPD1607 Approved
0.7368 Intermediate Similarity NPD7229 Phase 3
0.7356 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD4060 Phase 1
0.7355 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD3620 Phase 2
0.7355 Intermediate Similarity NPD943 Approved
0.7351 Intermediate Similarity NPD2797 Approved
0.7338 Intermediate Similarity NPD3268 Approved
0.7329 Intermediate Similarity NPD5536 Phase 2
0.732 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD8150 Discontinued
0.7308 Intermediate Similarity NPD1933 Approved
0.7301 Intermediate Similarity NPD5401 Approved
0.7292 Intermediate Similarity NPD5283 Phase 1
0.7285 Intermediate Similarity NPD1283 Approved
0.7284 Intermediate Similarity NPD7440 Discontinued
0.7278 Intermediate Similarity NPD3748 Approved
0.7267 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD3972 Approved
0.7261 Intermediate Similarity NPD6653 Approved
0.7255 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD2861 Phase 2
0.7246 Intermediate Similarity NPD6873 Phase 2
0.7244 Intermediate Similarity NPD2979 Phase 3
0.7234 Intermediate Similarity NPD7680 Approved
0.7233 Intermediate Similarity NPD1551 Phase 2
0.7222 Intermediate Similarity NPD2354 Approved
0.7222 Intermediate Similarity NPD2309 Approved
0.7222 Intermediate Similarity NPD3887 Approved
0.7209 Intermediate Similarity NPD1247 Approved
0.7208 Intermediate Similarity NPD6832 Phase 2
0.7208 Intermediate Similarity NPD4908 Phase 1
0.7204 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7177 Discontinued
0.72 Intermediate Similarity NPD3705 Approved
0.719 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD2798 Approved
0.7188 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6004 Phase 3
0.7188 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6002 Phase 3
0.7188 Intermediate Similarity NPD6005 Phase 3
0.7188 Intermediate Similarity NPD2346 Discontinued
0.7186 Intermediate Similarity NPD7028 Phase 2
0.7179 Intermediate Similarity NPD4062 Phase 3
0.7171 Intermediate Similarity NPD1876 Approved
0.717 Intermediate Similarity NPD4308 Phase 3
0.7161 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1006 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD228 Approved
0.7143 Intermediate Similarity NPD5958 Discontinued
0.7135 Intermediate Similarity NPD6971 Discontinued
0.7125 Intermediate Similarity NPD5404 Approved
0.7125 Intermediate Similarity NPD5406 Approved
0.7125 Intermediate Similarity NPD5405 Approved
0.7125 Intermediate Similarity NPD5408 Approved
0.7124 Intermediate Similarity NPD1203 Approved
0.7118 Intermediate Similarity NPD5978 Approved
0.7118 Intermediate Similarity NPD5977 Approved
0.7115 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD2313 Discontinued
0.7114 Intermediate Similarity NPD9268 Approved
0.7108 Intermediate Similarity NPD920 Approved
0.7107 Intermediate Similarity NPD7097 Phase 1
0.7102 Intermediate Similarity NPD3751 Discontinued
0.7095 Intermediate Similarity NPD7549 Discontinued
0.7091 Intermediate Similarity NPD3146 Approved
0.7091 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1281 Approved
0.707 Intermediate Similarity NPD6663 Approved
0.7069 Intermediate Similarity NPD5711 Approved
0.7069 Intermediate Similarity NPD5710 Approved
0.7059 Intermediate Similarity NPD5760 Phase 2
0.7059 Intermediate Similarity NPD5761 Phase 2
0.7055 Intermediate Similarity NPD1878 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data